Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

Research and Innovation Action · Running

Recon4IMD Reconstruction and Computational Modelling for Inherited Metabolic Diseases

Coordinator
University of Galway, Ireland
Runs
1 June 2023 to 31 May 2027
Status
Running
EU funding
€7.9m
Total cost
€7.9m
Partners
42 organisations in 13 countries
Type
Research and Innovation Action
Grant agreement
101080997

What the project is doing

In the project's own words, from its summary on CORDIS.

Our overall objectives are to accelerate the diagnosis, and enable personalised management, of inherited metabolic diseases (IMDs). Established academic technology for statistical genomic analysis, deep learning-based prediction of protein structure, and whole-body metabolic network modelling shall be applied to generate personalised computational models, given patient-derived genomic, transcriptomic, proteomic and metabolomic data.

To train diagnostic models, a comprehensive clinical team will recruit 1,945 diagnosed patients with a wide variety of IMDs, then validate the clinical utility of personalised computational models on a set of 685 undiagnosed patients. An enhanced human metabolic network reconstruction, especially for lipid metabolism, reaction kinetics and inherited metabolic disease pathways, will increase the predictive capacity of cellular and whole-body metabolic network models.

As an exemplar for other IMDs, personalised computational modelling will be used to identify compensatory and aggravating mechanisms that associate with clinical severity in Gaucher disease. The predictive capacity of personalised models will be validated by comparison with additional empirical investigations of protein structure and function as well as metabolomics, tracer-based metabolomics and proteomics of patient-derived in vitro disease models.

To maximise the potential for impact, personalised modelling software will be developed to be generally applicable to a broad variety of IMDs, and implemented in a way that is both accessible to clinicians and admissible to regulatory authorities. Sustainability will be promoted by development of a roadmap for a European foundation to aid personalised diagnosis and management of IMDs, informed by broad stakeholder consultation.

This is a unique opportunity to realise the potential of personalised computational modelling for a broad set of rare diseases, which is a field where European collaboration is an essential for progress.

Topics

Who is involved

OrganisationCityCountryRole
University of GalwayGalwayIrelandCoordinator
Medizinische Universitaet WienWienAustriaParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
Universitair Ziekenhuis AntwerpenEdegemBelgiumParticipant
Sib Swiss Institute of BioinformaticsGenfSwitzerlandAssociatedpartner
Vseobecna Fakultni Nemocnice V PrazePraha 2CzechiaParticipant
Eberhard Karls Universitaet TuebingenTuebingenGermanyParticipant
Klinikum Der Ludwig-Maximilians-Universitat MunchenMunchenGermanyThird party
Klinikum Der Technischen Universität München (tum Klinikum)MuenchenGermanyParticipant
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyParticipant
Medizinische Hochschule HannoverHannoverGermanyParticipant
Universitaet OsnabrueckOsnabrueckGermanyParticipant
Universitaetsklinikum FreiburgFreiburgGermanyParticipant
Universitaetsklinikum TuebingenTuebingenGermanyThird party
Universitaetsmedizin Der Johannes Gutenberg-Universitaet MainzMainzGermanyParticipant
Universitatsklinikum HeidelbergHeidelbergGermanyParticipant
Region HovedstadenHillerodDenmarkParticipant
Asociacion Instituto De Investigacion Sanitaria BiobizkaiaBarakaldo BizkaiaSpainParticipant
Fundacion Para La Investigacion Biomedica Del Hospital Universitario 12 De OctubreMadridSpainParticipant
Fundacion Publica Galega Instituto De Investigacion Sanitaria De Santiago De CompostelaSantiago De CompostelaSpainParticipant
Servicio Vasco de Salud OsakidetzaVitoria-GasteizSpainThird party
Children's Health IrelandDublinIrelandParticipant
Dundalk Institute of TechnologyDundalkIrelandParticipant
Mater Misericordiae University HospitalDublinIrelandParticipant
Azienda Ospedaliera Universitaria Meyer IrccsFirenzeItalyParticipant
Azienda Sanitaria Universitaria Friuli CentraleUdineItalyParticipant
Fondazione Irccs Istituto Neurologico Carlo BestaMilanoItalyParticipant
Ospedale Pediatrico Bambino GesuRomaItalyParticipant
Uniamo - Federazione Italiana Malattie Rare - Onlus AssociazioneRomaItalyParticipant
Academisch Ziekenhuis GroningenGroningenNetherlandsParticipant
Academisch Ziekenhuis MaastrichtMaastrichtNetherlandsThird party
Erasmus Universitair Medisch Centrum RotterdamRotterdamNetherlandsParticipant
Stichting Amsterdam UmcAmsterdamNetherlandsParticipant
Universitair Medisch Centrum UtrechtUtrechtNetherlandsParticipant
Universiteit LeidenLeidenNetherlandsParticipant
Universiteit MaastrichtMaastrichtNetherlandsParticipant
Oslo Universitetssykehus HfOsloNorwayParticipant
Vastra GotalandsregionenVanersborgSwedenParticipant
Belfast Health and Social Care TrustBelfastUnited KingdomAssociatedpartner
The Chancellor, Masters and Scholars of the University of OxfordOxfordUnited KingdomAssociatedpartner
University College LondonLondonUnited KingdomAssociatedpartner
University of Newcastle Upon TyneNewcastle Upon TyneUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI